Unique ID issued by UMIN | UMIN000027937 |
---|---|
Receipt number | R000032002 |
Scientific Title | Effect of test supplement on postprandial serum uric acid: A double blinded, placebo controlled, and cross over study |
Date of disclosure of the study information | 2017/07/05 |
Last modified on | 2017/12/26 09:35:09 |
Effect of test supplement on postprandial serum uric acid: A double blinded, placebo controlled, and cross over study
Effect of test supplement on postprandial serum uric acid
Effect of test supplement on postprandial serum uric acid: A double blinded, placebo controlled, and cross over study
Effect of test supplement on postprandial serum uric acid
Japan |
Healthy male adults
Not applicable | Adult |
Others
NO
This study aimed to verify the effect of test supplement on postprandial serum uric acid.
Efficacy
Exploratory
Explanatory
Not applicable
Postprandial serum uric acid
Urinary excretion of uric acid,
uric acid clearance, creatinine clearance, uric acid clearance/creatinine clearance ratio, blood functional ingredient and its metabolite concentrations
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
3
Prevention
Food |
Single intake of test food 1- single intake of test food 2- single intake of placebo
Single intake of placebo- single intake of test food 2- single intake of test food 1
Single intake of test food 2- single intake of placebo - single intake of test food 1
20 | years-old | <= |
65 | years-old | > |
Male
1.Subjects aged from 20 to 65 years old
1. Subjects who have been taking foods affecting the study results once a week or more
2. Subjects who have gout in the past or are currently receiving treatment for hyperuricemia or gout (including exercise therapy, dietary guidance)
3. Subjects who are under treatment or have history of diseases (urinary stone, kidney stone, rheumatoid arthritis) which may influence the outcome of the study
4. Subjects who routinely use analgesics (non-steroidal analgesics, steroidal analgesics, etc.).
5. Subjects who have diseases requiring continuous medication, or serious medical history who needed medication therapy
6. Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease)
7. Subjects with allergies to the test food in the study
8. Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study
9. Subjects who are judges as unsuitable for the study based on the results of background survey
10. Subjects who are judged as unsuitable for the study by the investigator for other reason
6
1st name | |
Middle name | |
Last name | Sayuri Matsuoka |
FANCL Corporation
Research Institute, Health science research center
12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa
045-820-3755
matsuoka@fancl.co.jp
1st name | |
Middle name | |
Last name | Yoshiki Shimizu |
FANCL Corporation
Research Institute, Health science research center
12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa
045-820-3755
shimizu_yoshiki@fancl.co.jp
FANCL Corporation
FANCL Corporation
Profit organization
Japan
NO
2017 | Year | 07 | Month | 05 | Day |
Unpublished
Completed
2017 | Year | 06 | Month | 22 | Day |
2017 | Year | 07 | Month | 06 | Day |
2017 | Year | 06 | Month | 26 | Day |
2017 | Year | 12 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032002
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |